Last refreshed: September 4, 2026 (US ET)
Back to holdings

KVUE

Defensive

KENVUE INC.

Consumer Staples·Personal Care ProductsYield: High (3-5%)

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.

Close · 3M

+8.35%

KVUE · 3M

+8.35%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 2 AI ETFs

LQAI1.770%

as of Sep 2

PQUS0.060%

as of Sep 1

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals10
Win rate10% (1/10)
Avg buy return-1.69%
LQAInow 1.770% of fund26 signals

LQAI · Weight increase · 2d

weight 1.690% → 1.770% (+0.080 pp)·stock down 2.1% in the 30 days before

Sep 2·entry $19.13·now $18.95Fresh

-0.94%
since Sep 2

LQAI · Weight decrease · 3d

weight 1.750% → 1.710% (-0.040 pp)·stock down 3.0% in the 30 days before

Aug 27·entry $19.20·now $18.95

-1.30%
since Aug 27

LQAI · Weight decrease · 2d

weight 1.750% → 1.720% (-0.030 pp)·stock down 2.7% in the 30 days before

Aug 26·entry $19.22·now $18.95

-1.40%
since Aug 26

LQAI · Weight increase · 2d

weight 1.680% → 1.750% (+0.070 pp)·stock up 0.8% in the 30 days before

Aug 24·entry $19.43·now $18.95Fresh

-2.47%
since Aug 24

LQAI · Weight increase · 2d

weight 1.630% → 1.700% (+0.070 pp)·stock up 0.6% in the 30 days before

Aug 19·entry $19.13·now $18.95Fresh

-0.94%
since Aug 19

LQAI · Weight decrease · 4d

weight 1.710% → 1.630% (-0.080 pp)·stock down 1.0% in the 30 days before

Aug 17·entry $18.79·now $18.95

+0.85%
since Aug 17

LQAI · Weight decrease · 3d

weight 1.710% → 1.660% (-0.050 pp)·stock up 0.9% in the 30 days before

Aug 14·entry $19.20·now $18.95

-1.30%
since Aug 14

LQAI · Weight decrease · 2d

weight 1.710% → 1.680% (-0.030 pp)·stock up 2.7% in the 30 days before

Aug 13·entry $19.20·now $18.95

-1.30%
since Aug 13

LQAI · Weight decrease · 2d

weight 1.730% → 1.710% (-0.020 pp)·stock down 2.3% in the 30 days before

Aug 10·entry $19.03·now $18.95

-0.42%
since Aug 10

LQAI · Weight decrease · 3d

weight 1.790% → 1.640% (-0.150 pp)·stock down 4.1% in the 30 days before

Aug 3·entry $19.01·now $18.95

-0.32%
since Aug 3

LQAI · Weight decrease · 2d

weight 1.790% → 1.680% (-0.110 pp)·stock down 0.5% in the 30 days before

Jul 31·entry $19.24·now $18.95

-1.51%
since Jul 31

LQAI · Weight increase · 3d

weight 1.620% → 1.790% (+0.170 pp)·stock up 3.8% in the 30 days before

Jul 29·entry $19.79·now $18.95Fresh

-4.24%
since Jul 29

LQAI · Weight increase · 2d

weight 1.620% → 1.740% (+0.120 pp)·stock up 3.2% in the 30 days before

Jul 28·entry $19.75·now $18.95Fresh

-4.05%
since Jul 28

LQAI · Weight increase · 3d

weight 1.580% → 1.650% (+0.070 pp)·stock up 3.0% in the 30 days before

Jul 17·entry $18.98·now $18.95Fresh

-0.16%
since Jul 17

LQAI · Weight increase · 2d

weight 1.580% → 1.630% (+0.050 pp)·stock up 4.2% in the 30 days before

Jul 16·entry $19.02·now $18.95Fresh

-0.37%
since Jul 16

LQAI · Weight decrease · 4d

weight 2.040% → 1.610% (-0.430 pp)·stock up 9.3% in the 30 days before

Jul 9·entry $19.18·now $18.95

-1.20%
since Jul 9

LQAI · Weight decrease · 3d

weight 2.040% → 1.640% (-0.400 pp)·stock up 8.9% in the 30 days before

Jul 8·entry $19.29·now $18.95

-1.76%
since Jul 8

LQAI · Weight decrease · 2d

weight 2.040% → 1.680% (-0.360 pp)·stock up 17.2% in the 30 days before

Jul 7·entry $19.78·now $18.95

-4.20%
since Jul 7

LQAI · Weight increase · 2d

weight 1.890% → 2.040% (+0.150 pp)·stock up 14.5% in the 30 days before

Jul 2·entry $19.83·now $18.95Fresh

-4.44%
since Jul 2

LQAI · Weight decrease · 2d

stock up 10.6% in the 30 days before

Jun 30·entry $19.11·now $18.95

-0.84%
since Jun 30

LQAI · Weight increase · 2d

stock up 7.2% in the 30 days before

Jun 24·entry $18.80·now $18.95Fresh

+0.80%
since Jun 24

LQAI · Weight decrease · 3d

stock up 3.1% in the 30 days before

Jun 22·entry $17.86·now $18.95

+6.10%
since Jun 22

LQAI · Weight decrease · 2d

stock up 5.7% in the 30 days before

Jun 18·entry $18.12·now $18.95

+4.58%
since Jun 18

LQAI · Weight decrease · 3d

stock up 6.2% in the 30 days before

Jun 15·entry $18.25·now $18.95

+3.84%
since Jun 15

LQAI · Weight decrease · 2d

stock up 5.5% in the 30 days before

Jun 12·entry $18.14·now $18.95

+4.47%
since Jun 12

LQAI · Weight decrease · 2d

stock up 1.9% in the 30 days before

Jun 9·entry $17.92·now $18.95

+5.75%
since Jun 9
AIEQno longer held2 signals

AIEQ · Exit · 1d

stock up 11.4% in the 30 days before

Jul 1·entry $19.33·now $18.95

-1.97%
since Jul 1

AIEQ · Weight increase · 2d

stock up 8.4% in the 30 days before

Jun 25·entry $18.96·now $18.95Fresh

-0.05%
since Jun 25

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of May 31

AIEQ recently made a new entry into Kenvue, indicating a positive signal from that AI, while LQAI showed a recent trend of decreasing its weight after a slight increase. This mixed AI sentiment contrasts with the framework's overall 'Fail' verdict, which is primarily driven by the inability to confirm critical financial health metrics and valuation.

  • Circle of CompetenceKenvue's position in consumer staples with established brands suggests predictable unit economics suitable for long-term cash flow projections.
  • Economic MoatThe company benefits from strong brand power and established market positions for its consumer health products, creating durable competitive advantages.
  • ManagementSpecific information regarding management's candor, capital allocation discipline, or ownership stake is not provided.
  • Financial HealthInsufficient financial data, including 10-year ROE trend, operating margins, debt profile, and owner earnings, prevents a comprehensive assessment of financial health.
  • Margin of SafetyWithout an intrinsic value estimate, it is not possible to determine if the current price offers a margin of safety.

Kenvue, a consumer staples company with strong brands, passes the circle of competence and economic moat stages. However, a comprehensive assessment of its financial health, management quality, and intrinsic value is hindered by insufficient public data for several key criteria, leading to an overall 'Fail' verdict within this framework.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.